Clinical Trial Update: Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir) [Phase 3]

View source ↗

Summary

Completed Phase 3 observational study evaluating a protease inhibitor–containing regimen in HIV patients with PI mutations selected during prior Fosamprenavir t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fosamprenavir (fosamprenavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 3 | Status: COMPLETED